Glycopeptide-induced cutaneous adverse reaction: Results of an immunoallergic investigation in eight patients;Toxidermies aux glycopeptides : résultats des explorations immunoallergologiques dans une série de huit cas

Annales de Dermatologie et de Venereologie

Volumn 137, Issue 2, 2010, Pages 101-105

  Perrin Lamarre, A ^a   Petitpain, N ^b   Trechot, P ^b   Cuny, J F ^a   Schmutz, J L ^a   Barbaud, A ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Cutaneous adverse drug reactions; Drug patch tests; Drug skin tests; Glycopeptides; Intradermal tests

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRESS SYNDROME; FEMALE; HUMAN; INTRACUTANEOUS TEST; MACULOPAPULAR RASH; MALE; PRICK TEST; SKIN ALLERGY; SKIN TEST; URTICARIA; AGED; DRUG ERUPTION; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN TESTS; TEICOPLANIN; VANCOMYCIN;

EID: 76549134307     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2010.01.005     Document Type: Article

References (27)

1. Wood M.J. Comparative safety of teicoplanin and vancomycin. J Chemother 12 Supl 5 (2000) 21-25
2. Khurana C., and De Belder M.A. Red man syndrome after vancomycin : potential cross-reactivity with teicoplanin. Postgrad Med J 75 (1999) 41-43
3. Asero R. Teicoplanin-induced anaphylaxis. Allergy 61 (2006) 1370
4. Grek V., Andrien F., Collignon J., and Fillet G. Allergic cross-reaction of teicoplanin and vancomycin. J Antimicrob Chemother 28 (1991) 476-477
5. Knudsen J.D., and Pedersen M. IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin. Scand J Infect Dis 24 (1992) 395-396
6. Anne S., Middleton Jr. E., and Reisman R.E. Vancomycin anaphylaxis and successful desensitization. Ann Allergy 73 (1994) 402-404
7. Schlemmer B., Falkman H., Boudjadja A., Jacob L., and Le Gall J.R. Teicoplanin for patients allergic to vancomycin. N Eng J Med 318 (1988) 1127-1128
8. De Vries E., van Weel-Sipman M.H., and Vossen J.M. A four-year-old child with teicoplanin allergy but no evidence of cross-reaction with vancomycin. Pediatr Infect Dis J 13 (1994) 167
9. McElrath M.J., Goldberg D., and Neu H.C. Allergic cross-reactivity of teicoplanin and vancomycin. Lancet 1 (1986) 47
10. Hsu S.I. Biopsy-proved acute tubulointerstitial nephritis and toxic epidermal necrolysis associated with vancomycin. Pharmacotherapy 21 (2001) 1233-1239
11. Chu C.Y., Wu J., Jean S.S., and Sun C.C. Acute generalized exanthematous pustulosis due to teicoplanin. Dermatology 202 (2001) 141-142
12. Joshi P.P., and Ahmed N. Fixed drug eruption with vancomycin. Ann Pharmacother 36 (2002) 1104
13. Marshall C., Street A., and Galbraith K. Glycopeptide-induced vasculitis - cross-reactivity between vancomycin and teicoplanin. J Infect 37 (1998) 82-83
14. Tamagawa-Mineoka R., Katoh N., Nara T., Nishimura Y., Yamamoto S., and Kishimoto S. DRESS syndrome caused by teicoplanin and vancomycin, associated with reactivation of human herpesvirus-6. Int J Dermatol 46 (2007) 654-655
15. Kwon H.S., Chang Y.S., Jeong Y.Y., Lee S.M., Song W.J., Kim H.B., et al. A case of hypersensitivity syndrome to both vancomycin and teicoplanin. J Korean Med Sci 21 (2006) 1108-1110
16. Begaud B., Evreux J.C., Jouglard J., and Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 40 (1985) 111-118
17. Barbaud A., Gonçalo M., Bruynzeel D., and Bircher A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 45 (2001) 321-328
18. Polk R.E., Israel D., Wang J., Venitz J., Miller J., and Stotka J. Vancomycin skin tests and prediction of "red man syndrome" in healthy volunteers. Antimicrob Agents Chemother 37 (1993) 2139-2143
19. El Harrar E., Miloudi Y., and Bensaid A. Une manifestation biologique inhabituelle du red man syndrome. Ann Fr Anesth Reanim 23 (2004) 1015-1016
20. Rimailho A., Riou B., Teboul J.L., Richard C., and Auzepy P. Erythrodermie immuno-allergique à la vancomycine. Press Med 13 (1984) 567
21. Bernedo N., González I., Gastaminza G., Audicana M., Fernández E., and Muñoz D. Positive patch test in vancomycin allergy. Contact Dermatitis 45 (2001) 43
22. Hwu J.J., Chen K.H., Hsu W.M., Lai J.Y., and Li Y.S. Ocular hypersensitivitiy to topical vancomycin in a case of chronic endophthalmitis. Cornea 24 (2005) 754-756
23. Davenport A. Allergic cross-reactivity to teicoplanin and vancomycin. Nephron 63 (1993) 482
24. Dellestable P., Weber-Muller F., Tréchot P., Vernassière C., Schmutz J.L., and Barbaud A. Deux médicaments de même imputabilité dans une toxidermie (deux cas) : limite des tests épicutanés. Ann Dermatol Venereol 134 (2007) 655-658
25. Barbaud A. Skin testing in delayed reactions to drugs. Immunol Allergy Clin North Am 29 (2009) 517-535
26. Romano A., Viola M., Mondino C., Pettinato R., Di Fonso M., Papa G., et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 129 (2002) 169-174
27. Brockow K., Romano A., Aberer W., Bircher A.J., Barbaud A., Bonadonna P., et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media - a European multicenter study. Allergy 64 (2009) 234-241